Graft protein C entrapment is associated with reduced phagocyte activation during reperfusion in human liver transplantation

Critical Care Medicine

Volumn 34, Issue 2, 2006, Pages 426-432

  Ilmakunnas, Minna ^a,c   Pesonen, Eero J ^a   Höckerstedt, Krister ^a   Mäkisalo, Heikki ^a   Fernandez, Jose A ^d   Griffin, John H ^d   Repo, Heikki ^a,c   Siitonen, Sanna ^a   Petäjä, Jari ^b,e  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e JORVI HOSPITAL   (Finland)

Author keywords

Activated protein C; Ischemia reperfusion; Liver transplantation; Monocyte; Natural anticoagulants; Neutrophil

Indexed keywords

ACTIVATED PROTEIN C; CD11B ANTIGEN; L SELECTIN; PROTEIN C;

ADULT; ARTICLE; BLOOD SAMPLING; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL OBSERVATION; FEMALE; HEPATIC VEIN; HUMAN; LEUKOCYTE ACTIVATION; LEUKOCYTE DIFFERENTIAL COUNT; LIVER FAILURE; LIVER FUNCTION; LIVER PERFUSION; LIVER TRANSPLANTATION; MALE; MONOCYTE; NEUTROPHIL; OUTCOME ASSESSMENT; PHAGOCYTE; PORTAL VEIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE; VEIN BLOOD FLOW;

EID: 31344438362     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000198108.38349.28     Document Type: Article

References (51)

1. White B, Schmidt M, Murphy C, et al: Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor κB (NF-κB) and tumour necrosis factor α (TNF-α) production in the THP-1 monocytic cell line. Br J Haematol 2000; 110:130-134
2. Joyce DE, Gelbert L, Ciaccia A, et al: Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 2001; 276:11119-11203
3. Joyce DE, Grinnell B: Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-κB. Crit Care Med 2002; 30:S288-S293
4. Grinnell BW, Hermann RB, Yan SB: Human protein C inhibits selectin-mediated cell-adhesion: Role of unique fucosylated oligosaccharide. Glycobiology 1994; 4:221-225
5. Murakami K, Okajima K, Uchiba M, et al: Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 1996; 87:642-647
6. Murakami K, Okajima K, Uchiba M, et al: Activated protein C prevents LPS-induced pulmonary vascular injury by inhibiting cytokine production. Am J Physiol 1997; 272:L197-L202
7. Esmon CT, Taylor FB, Snow TR: Inflammation and coagulation. Linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost 1991; 66:160-165
8. Taylor FB, Chang A, Esmon CT, et al: Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987; 79:918-925
9. Roback MG, Stack AM, Thompson C, et al: Activated protein C concentrate for the treatment of meningococcal endotoxin shock in rabbits. Shock 1998; 9:138-142
10. Schoots IG, Levi M, van Vliet AK, et al: Inhibition of coagulation and inflammation by activated protein C or antithrombin reduces intestinal ischemia/reperfusion injury in rats. Crit Care Med 2004; 32:1375-1383
11. Bernard GR, Vincent J, Laterre P, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
12. Derhaschnig U, Reiter R, Knöbl P, et al: Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis and inflammation in acute human endotoxemia. Blood 2003; 102:2093-2098
13. Dhainaut J-F, Yan SB, Margolis BD, et al: Drotrecogin alfa (activated) (recombinant human activated protein C) reduces host coagulopathy response in patients with severe sepsis. Thromb Haemost 2003; 90:642-653
14. O'Brien JM Jr, Abraham E: Human models of endotoxemia and recombinant human activated protein C. Crit Care Med 2004; 32:S202-S208
15. Caldwell-Kenkel JC, Currin RT, Tanaka Y, et al: Kupffer cell activation and endothelial cell damage after storage of rat livers: Effects of reperfusion. Hepatology 1991; 13:83-95
16. Carles J, Fawaz R, Hamoudi NE, et al: Preservation of human liver grafts in UW solution. Ultrastructural evidence for endothelial and Kupffer cell activation during cold ischemia and after ischemia-reperfusion. Liver 1994; 14:50-56
17. Kobayashi Y, Yoshimura N, Nakamura K, et al: Expression of tissue factor in hepatic ischemia-reperfusion injury of the rat. Transplantation 1998; 66:708-716
18. Pesonen EJ, Höckerstedt K, Mäkisalo H, et al: Transhepatic neutrophil and monocyte activation during clinical liver transplantation. Transplantation 2000; 69:1458-1464
19. Fugger R, Hamilton G, Steininger R, et al: Intraoperative estimation of endotoxin, TNF-alpha, and IL-6 in orthotopic liver transplantation and their relation to rejection and postoperative infection. Transplantation 1991; 52:302-306
20. Maring JK, Klompmaker IJ, Zwaveling JH, et al: Endotoxins and cytokines during liver transplantation: Changes in plasma levels and effects on clinical outcome. Liver Transpl 2000; 6:480-488
21. Himmelreich G, Jochum M, Bechstein WO, et al: Mediators of leukocyte activation play a role in disseminated intravascular coagulation during orthotopic liver transplantation. Transplantation 1994; 57:354-358
22. Bzeizi KI, Jalan R, MacGregor I, et al: Neutrophil elastase: A determinant of endothelial damage and reperfusion injury after liver transplantation? Transplantation 1996; 62:916-920
23. Ishii H, Horie S, Kizaki K, et al: Retinoic acid counteracts both the downregulation of thrombomodulin and the induction of tissue factor in cultured human endothelial cells exposed to tumor necrosis factor. Blood 1992; 80:2556-2562
24. Himmelreich G, Riewald M, Rosch R, et al: Thrombomodulin: A marker for endothelial damage during orthotopic liver transplantation. Am J Hematol 1994; 47:1-5
25. Harper PL, Luddington RJ, Jennings I, et al: Coagulation changes following hepatic revascularization during liver transplantation. Transplantation 1989; 48:603-607
26. Okajima K, Harada N, Kushimoto S, et al: Role of microthrombus in the development of ischemia/reperfusion-induced liver injury in rats. Thromb Haemost 2002; 88:473-480
27. Kakizoe S, Yanaga K, Starzl TE, et al: Evaluation of protocol before transplantation and reperfusion biopsies from human orthotopic liver allografts: Considerations of preservation and early immunological injury. Hepatology 1990; 11:932-941
28. Levi M, Choi G, Schoots I, et al: Beyond sepsis: Activated protein C and ischemia-reperfusion injury. Crit Care Med 2004; 32:S309-S312
29. Ilmakunnas M, Petäjä J, Höckerstedt K, et al: Activation of protein C during reperfusion in clinical liver transplantation. Transplantation 2003; 75:467-472
30. Kalayoglu M, Sollinger HW, Stratta RJ, et al: Extended preservation of the liver for clinical transplantation. Lancet 1988; 8586:617-619
31. Gruber A, Griffin JH: Direct detection of activated protein C in blood from human subjects. Blood 1992; 79:2340-2348
32. Repo H, Jansson S-E, Leirisalo-Repo M: Flow cytometric determination of CD11b upregulation in vivo. J Immunol Methods 1993; 164:193-202
33. Repo H, Jansson S-E, Leirisalo-Repo M: Anticoagulant selection influences flow cytometric determination of CD11b upregulation in vivo and ex vivo. J Immunol Methods 1995; 185:65-79
34. Esmon CT: Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation. Crit Care Med 2001; 29:S48-S51
35. Esmon CT, Xu J, Gu J, et al: Endothelial protein C receptor. Thromb Haemost 1999; 82:251-258
36. Esmon CT: Role of coagulation inhibitors in inflammation. Thromb Haemost 2001; 86:51-56
37. Shibata M, Kumar SR, Amar A, et al: Antiinflammatory, antithrombotic and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation 2001; 103:1799-1805
38. Petäjä J, Pesonen EJ, Fernandez JA, et al: Cardiopulmonary bypass and activation of antithrombotic plasma protein C. J Thorac Cardiovasc Surg 1999; 118:422-429
39. Gu JM, Katsuura Y, Ferrell GL, et al: Endotoxin and thrombin elevate rodent endothelial cell protein C receptor mRNA levels and increase receptor shedding in vivo. Blood 2000; 95:1687-1693
40. Taylor FB Jr, Peer GT, Lockhart MS, et al: Endothelial protein C receptor plays an important role in protein C activation in vivo. Blood 2001; 97:1685-1688
41. Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, et al: The endothelial cell protein C receptor augments protein C activation by thrombin-thrombomodulin complex. Proc Natl Acad Sci U S A 1996; 93:10 212-216
42. Suehiro T, Boros P, Sheiner P, et al: Effluent levels of thrombomodulin predict early graft function in clinical liver transplantation. Liver 1997; 17:224-229
43. Sturn DH, Kaneider NC, Feistritzer C, et al: Expression and function of the endothelial protein C receptor in human neutrophils. Blood 2003; 102:1499-1505
44. Kurosawa S, Esmon CT, Stearns-Kurosawa DJ: The soluble endothelial protein C receptor binds to activated neutrophils: Involvement of proteinase-3 and CD11b/CD18. J Immunol 2000; 165:4697-4703
45. Joyce DE, Nelson DR, Grinnell BW: Leukocyte and endothelial cell interactions in sepsis: Relevance of the protein C pathway. Crit Care Med 2004; 32:S280-S286
46. Yamaguchi Y, Hisama N, Okajima K, et al: Pretreatment with activated protein C or active human urinary thrombomodulin attenuates the production of cytokine-induced neutrophil chemoattractant following ischemia/reperfusion injury in rat liver. Hepatology 1997; 25:1136-1140
47. Hirose K, Okajima K, Taoka Y, et al: Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation. Ann Surg 2000; 232:272-280
48. Mizutani A, Okajima K, Uchiba M, et al: Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood 2000; 95:3781-3787
49. Petäjä J, Pesonen EJ, Fernandez AJ, et al: Activated protein C and inflammation in human myocardium after heart surgery. Am J Hematol 2001; 67:210-212
50. Harper PL, Luddington RJ, Carrell RW, et al: Protein C deficiency and portal thrombosis in liver transplantation in children. Lancet 1988; II(8617):924-927
51. Petäjä J, Manco-Johnson M: Protein C pathway in infants and children. Semin Thromb Hemost 2003; 23:349-361